Calithera Biosciences Company Profile (NASDAQ:CALA)

About Calithera Biosciences

Calithera Biosciences logoCalithera Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. It is engaged in developing agents that take advantage of the metabolic requirements of tumor cells and cancer-fighting immune cells, such as cytotoxic T-cells. Its lead product candidate, CB-839, is a critical enzyme in tumor cells. Its other product candidate, CB-1158, which is an enzyme that depletes the amino acid arginine, a key metabolic nutrient for T-cells. Its lead preclinical program in tumor immunology is directed at developing inhibitors of the enzyme arginase and may provide a therapeutic agent for the target. CB-839 is a selective, reversible and orally bioavailable inhibitor of human glutaminase. Hexokinase is an enzyme in the pathway that allows cancer cells to convert glucose to energy to fuel cancer cell growth.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CALA
  • CUSIP:
Key Metrics:
  • Previous Close: $3.23
  • 50 Day Moving Average: $3.23
  • 200 Day Moving Average: $4.71
  • 52-Week Range: $2.87 - $10.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.75
  • P/E Growth: -0.02
  • Market Cap: $62.95M
  • Outstanding Shares: 19,489,000
  • Beta: 2.45
Additional Links:
Companies Related to Calithera Biosciences:

Analyst Ratings

Consensus Ratings for Calithera Biosciences (NASDAQ:CALA) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.33 (285.42% upside)

Analysts' Ratings History for Calithera Biosciences (NASDAQ:CALA)
Show:
DateFirmActionRatingPrice TargetDetails
6/8/2016JMP SecuritiesReiterated RatingBuyView Rating Details
5/12/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$20.00 -> $12.00View Rating Details
11/10/2015Leerink SwannLower Price TargetOutperform$19.00 -> $13.00View Rating Details
7/24/2015Citigroup Inc.Initiated CoverageBuy$11.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Calithera Biosciences (NASDAQ:CALA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q2($0.52)($0.55)ViewListenView Earnings Details
5/10/2016Q1($0.47)($0.52)ViewListenView Earnings Details
3/15/2016Q415($0.56)($0.44)ViewListenView Earnings Details
11/9/2015Q3($0.52)($0.49)ViewListenView Earnings Details
8/10/2015Q215($0.45)($0.44)ViewListenView Earnings Details
11/17/2014($0.28)($16.85)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Calithera Biosciences (NASDAQ:CALA)
Current Year EPS Consensus Estimate: $-2.16 EPS
Next Year EPS Consensus Estimate: $-1.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.52)($0.52)($0.52)
Q3 20161($0.56)($0.56)($0.56)
Q4 20161($0.60)($0.60)($0.60)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Calithera Biosciences (NASDAQ:CALA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Calithera Biosciences (NASDAQ:CALA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2015Curtis HechtVPSell970$6.58$6,382.60View SEC Filing  
9/23/2015Adage Capital Partners Gp LlcMajor ShareholderBuy106,968$6.03$645,017.04View SEC Filing  
9/4/2015Adage Capital Partners Gp LlcMajor ShareholderBuy90,300$5.93$535,479.00View SEC Filing  
8/28/2015Adage Capital Partners Gp LlcMajor ShareholderBuy172,126$5.27$907,104.02View SEC Filing  
10/15/2014Adage Capital Partners Gp LlcMajor ShareholderBuy181,700$6.96$1,264,632.00View SEC Filing  
10/7/2014Jean GeorgeDirectorBuy300,000$10.00$3,000,000.00View SEC Filing  
10/7/2014Morgenthaler Venture PartnersMajor ShareholderBuy350,000$10.00$3,500,000.00View SEC Filing  
10/1/2014Adage Capital Partners Gp LlcMajor ShareholderBuy800,000$10.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Calithera Biosciences (NASDAQ:CALA)
DateHeadline
investornewswire.com logoCalithera Biosciences, Inc. (NASDAQ:CALA) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:CALA)
www.investornewswire.com - August 26 at 4:14 PM
News IconStock Tracking Lower for the Quarter: Calithera Biosciences, Inc. (NASDAQ:CALA) - Post News (NASDAQ:CALA)
www.kentuckypostnews.com - August 21 at 8:42 AM
finance.yahoo.com logoCALITHERA BIOSCIENCES, INC. Financials (NASDAQ:CALA)
finance.yahoo.com - August 19 at 4:44 PM
kcregister.com logoMarket Movers: Tremor Video, Inc. (NYSE:TRMR), Calithera ... - KC Register (NASDAQ:CALA)
www.kcregister.com - August 12 at 4:03 PM
seekingalpha.com logoCalithera Biosciences' (CALA) CEO Susan Molineaux on Q2 2016 Results - Earnings Call Transcript (NASDAQ:CALA)
seekingalpha.com - August 10 at 9:36 PM
finance.yahoo.com logoCalithera Biosciences Appoints Suzy Jones to Board of Directors (NASDAQ:CALA)
finance.yahoo.com - August 10 at 9:35 PM
biz.yahoo.com logoCALITHERA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CALA)
biz.yahoo.com - August 10 at 9:35 PM
finance.yahoo.com logoEdited Transcript of CALA earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:CALA)
finance.yahoo.com - August 10 at 3:31 PM
seekingalpha.com logoCalithera Biosciences' (CALA) CEO Susan Molineaux on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:CALA)
seekingalpha.com - August 9 at 10:39 PM
sg.finance.yahoo.com logoCalithera reports 2Q loss (NASDAQ:CALA)
sg.finance.yahoo.com - August 9 at 10:39 PM
finance.yahoo.com logoCalithera Biosciences Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:CALA)
finance.yahoo.com - August 9 at 5:12 PM
biz.yahoo.com logoCALITHERA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:CALA)
biz.yahoo.com - August 9 at 5:12 PM
biz.yahoo.com logoCalithera Biosciences Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:CALA)
biz.yahoo.com - August 9 at 5:12 PM
biz.yahoo.com logoQ2 2016 Calithera Biosciences Inc Earnings Release - Time Not Supplied (NASDAQ:CALA)
biz.yahoo.com - August 9 at 12:57 PM
News IconNotable Runners: Ultrapar Participacoes SA (ADR)(NYSE:UGP), Calithera Biosciences Inc (NASDAQ:CALA) - NYSE Journal (press release) (NASDAQ:CALA)
stockznews.com - August 8 at 4:05 PM
finance.yahoo.com logoCalithera Announces Enrollment of First Patient in CB-839 in Combination with Checkpoint Modulator (NASDAQ:CALA)
finance.yahoo.com - August 4 at 12:41 PM
finance.yahoo.com logoCalithera Biosciences to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016 (NASDAQ:CALA)
finance.yahoo.com - August 2 at 4:11 PM
ftsenews.co.uk logoCalithera Biosciences, Inc. (NASDAQ:CALA) Updated Price Targets - FTSE News (NASDAQ:CALA)
www.ftsenews.co.uk - July 30 at 1:47 PM
streetinsider.com logoCalithera Biosciences (CALA) Announces FDA Acceptance of IND Application for CB-1158 (NASDAQ:CALA)
www.streetinsider.com - July 25 at 4:38 PM
streetinsider.com logoCalithera Biosciences (CALA) Announces FDA Acceptance of IND Application for CB-1158 - StreetInsider.com (NASDAQ:CALA)
www.streetinsider.com - July 25 at 4:38 PM
finance.yahoo.com logoCalithera Biosciences Announces FDA Acceptance of Investigational New Drug Application for CB-1158, a Novel Arginase Inhibitor Targeting an Immune Metabolic Checkpoint (NASDAQ:CALA)
finance.yahoo.com - July 25 at 8:00 AM
News IconChecking in on Stock Volatility for: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 21 at 9:36 PM
News IconBiotech news that matter for investors: Calithera Biosciences, Inc. (NASDAQ:CALA), Relypsa, Inc. (NASDAQ:RLYP) - The Voice Registrar (NASDAQ:CALA)
voiceregistrar.com - July 20 at 5:07 PM
News IconHeightened Volatility Spotted on Shares of: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 19 at 4:07 PM
News IconInvestor Watch: Volatility Recap on Shares of: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 19 at 10:15 AM
investing.com logoCalithera Biosciences Inc: A Big Bounce Could Be Brewing (NASDAQ:CALA)
www.investing.com - July 18 at 9:03 AM
News IconIncreased Volatility Noted on Shares of: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 17 at 3:53 PM
News IconIt Seems Calithera Biosciences Inc Will Go Down. Have Another Big Decline - Consumer Eagle (NASDAQ:CALA)
www.consumereagle.com - July 16 at 4:00 PM
News IconNoting Unusual Volume on Shares of Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 16 at 4:00 PM
News IconShares Experiencing a Downtrend: Calithera Biosciences, Inc. (NASDAQ:CALA) - TGP (NASDAQ:CALA)
telanaganapress.com - July 16 at 4:00 PM
News IconShares Moving Down on the Week: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 16 at 4:00 PM
fortune.com logoWhich way Calithera Biosciences, Inc. (NASDAQ:CALA) insiders are heading - Review Fortune (NASDAQ:CALA)
reviewfortune.com - July 16 at 4:00 PM
News IconCalithera Biosciences Incorporated (NASDAQ:CALA) Short Interest Decreased By 3.29% - Consumer Eagle (NASDAQ:CALA)
www.consumereagle.com - July 14 at 9:32 PM
News IconEye on Stock Volatility for: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 14 at 9:32 PM
247wallst.com logoImmunoGen, CVR Top Thursday’s 52-Week Low Club (NASDAQ:CALA)
247wallst.com - July 14 at 4:04 PM
fidaily.com logoCalithera Biosciences, Inc. (CALA) Hits a New 52-Week Low - Finance Daily (NASDAQ:CALA)
www.fidaily.com - July 13 at 4:06 PM
News IconCalithera Biosciences (NASDAQ:CALA) First Quarter Institutional Investor Sentiment Steady - Consumer Eagle (NASDAQ:CALA)
www.consumereagle.com - July 13 at 4:06 PM
investornewswire.com logoStrong Sell Calls For Calithera Biosciences, Inc. (NASDAQ:CALA) At 0 - Investor Newswire (NASDAQ:CALA)
www.investornewswire.com - July 13 at 4:06 PM
fidaily.com logoCalithera Biosciences, Inc. (CALA) Sees New 52-Week Low - Finance Daily (NASDAQ:CALA)
www.fidaily.com - July 12 at 8:13 AM
News IconWere Analysts Bullish Calithera Biosciences Inc (NASDAQ:CALA) This Week? - Press Telegraph (NASDAQ:CALA)
presstelegraph.com - July 12 at 8:13 AM
News IconCalithera Biosciences Incorporated (NASDAQ:CALA) Shorts Decreased by 3.29% After Short Covering - Press Telegraph (NASDAQ:CALA)
presstelegraph.com - July 10 at 3:56 PM
fidaily.com logoCalithera Biosciences, Inc. (CALA) Reached a New 52-Week Low - Finance Daily (NASDAQ:CALA)
www.fidaily.com - July 9 at 8:32 AM
tradecalls.org logoCalithera Biosciences (CALA) : Analyst Rating Update - Trade Calls (NASDAQ:CALA)
www.tradecalls.org - July 7 at 9:17 PM
News IconFollowing Unusual Volume for: Calithera Biosciences, Inc. (NASDAQ:CALA) - Engelwood Daily (NASDAQ:CALA)
www.engelwooddaily.com - July 7 at 9:17 PM
investornewswire.com logoCalithera Biosciences, Inc. (NASDAQ:CALA) Expected to Reach Highs Of $11 - Investor Newswire (NASDAQ:CALA)
www.investornewswire.com - July 6 at 9:50 PM
News IconWhat's Next for Calithera Biosciences Inc After Reaching All-Time Low? - Press Telegraph (NASDAQ:CALA)
presstelegraph.com - July 6 at 4:08 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead Calithera Biosciences, Inc. (NASDAQ:CALA) - Fiscal Standard (NASDAQ:CALA)
www.fiscalstandard.com - July 4 at 3:54 PM
ftsenews.co.uk logoNew Broker Ratings For Calithera Biosciences, Inc. (NASDAQ:CALA) - FTSE News (NASDAQ:CALA)
www.ftsenews.co.uk - July 1 at 12:07 PM
News IconCalithera Biosciences Incorporated (NASDAQ:CALA) Sellers Covered 3.29% of Their Shorts - Press Telegraph (NASDAQ:CALA)
presstelegraph.com - June 29 at 9:06 PM
News IconCalithera Biosciences Inc Can't Be More Risky. Trades Sigfnicicantly Lower - Press Telegraph (NASDAQ:CALA)
presstelegraph.com - June 29 at 4:01 PM

Social

Calithera Biosciences (NASDAQ:CALA) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff